These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10655394)

  • 1. Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial.
    Cha TA; Kao K; Zhao J; Fast PE; Mendelman PM; Arvin A
    J Clin Microbiol; 2000 Feb; 38(2):839-45. PubMed ID: 10655394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trial.
    Durviaux S; Treanor J; Beran J; Duval X; Esen M; Feldman G; Frey SE; Launay O; Leroux-Roels G; McElhaney JE; Nowakowski A; Ruiz-Palacios GM; van Essen GA; Oostvogels L; Devaster JM; Walravens K
    Clin Vaccine Immunol; 2014 Mar; 21(3):271-9. PubMed ID: 24371255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of influenza viruses collected from young children in Uberlandia, Brazil - from 2001 to 2010.
    de Mattos Silva Oliveira TF; Yokosawa J; Motta FC; Siqueira MM; da Silveira HL; Queiróz DA
    BMC Infect Dis; 2015 Feb; 15():71. PubMed ID: 25886886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants.
    Janjua NZ; Skowronski DM; De Serres G; Dickinson J; Crowcroft NS; Taylor M; Winter AL; Hottes TS; Fonseca K; Charest H; Drews SJ; Sabaiduc S; Bastien N; Li Y; Gardy JL; Petric M
    J Infect Dis; 2012 Jun; 205(12):1858-68. PubMed ID: 22492921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza A viruses possessing type B hemagglutinin and neuraminidase: potential as vaccine components.
    Horimoto T; Iwatsuki-Horimoto K; Hatta M; Kawaoka Y
    Microbes Infect; 2004 May; 6(6):579-83. PubMed ID: 15158192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine].
    Kiseleva IV; Bazhenova EA; Larionova NV; Fedorova EA; Dubrovina IA; Isakova-Sivak IN; Rudenko LG
    Vopr Virusol; 2013; 58(5):26-31. PubMed ID: 24640168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic and genomic characterization of human influenza A and B viruses circulating in Argentina after the introduction of influenza A(H1N1)pdm09.
    Russo ML; Pontoriero AV; Benedetti E; Czech A; Avaro M; Periolo N; Campos AM; Savy VL; Baumeister EG
    J Med Microbiol; 2014 Dec; 63(Pt 12):1626-1637. PubMed ID: 25351708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine.
    Vesikari T; Karvonen A; Korhonen T; Edelman K; Vainionpää R; Salmi A; Saville MK; Cho I; Razmpour A; Rappaport R; O'Neill R; Georgiu A; Gruber W; Mendelman PM; Forrest B;
    Pediatr Infect Dis J; 2006 Jul; 25(7):590-5. PubMed ID: 16804427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplex Reverse Transcription-PCR for Simultaneous Surveillance of Influenza A and B Viruses.
    Zhou B; Deng YM; Barnes JR; Sessions OM; Chou TW; Wilson M; Stark TJ; Volk M; Spirason N; Halpin RA; Kamaraj US; Ding T; Stockwell TB; Salvatore M; Ghedin E; Barr IG; Wentworth DE
    J Clin Microbiol; 2017 Dec; 55(12):3492-3501. PubMed ID: 28978683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotyping and screening of reassortant live-attenuated influenza B vaccine strain.
    Lee EY; Lee KH; Jung EJ; Jang YH; Seo SU; Kim HA; Seong BL
    J Virol Methods; 2010 May; 165(2):133-8. PubMed ID: 19883691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine].
    Kiseleva IV; Voeten JT; Teley LC; Larionova NV; Dubrovina IA; Berdygulova ZhA; Bazhenova EA; van den Bosch H; Heldens JG; Rudenko LG
    Mol Gen Mikrobiol Virusol; 2011; (4):29-36. PubMed ID: 22312898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics.
    Lu B; Zhou H; Ye D; Kemble G; Jin H
    J Virol; 2005 Jun; 79(11):6763-71. PubMed ID: 15890915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Basis of Attenuation of Cold-Adapted Influenza Strain B/Leningrad/14/17/55 - Backup Master Donor Virus for Influenza Type B Live Attenuated Vaccines.
    Krutikova EV; Stepanova EA; Wong PF; Kiseleva IV; Grigor'eva EP; Rudenko LG
    Bull Exp Biol Med; 2020 Mar; 168(5):669-672. PubMed ID: 32248454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic stability of live, cold-adapted influenza virus components of the FluMist/CAIV-T vaccine throughout the manufacturing process.
    Buonagurio DA; Bechert TM; Yang CF; Shutyak L; D'Arco GA; Kazachkov Y; Wang HP; Rojas EA; O'Neill RE; Spaete RR; Coelingh KL; Zamb TJ; Sidhu MS; Udem SA
    Vaccine; 2006 Mar; 24(12):2151-60. PubMed ID: 16413951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influenza activity in China from 2000 to 2001].
    Zhang Y; Li Z; Guo JF; Wang M; Wen LY; Guo YJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jan; 24(1):4-8. PubMed ID: 12678953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Restriction analysis of genome composition of live influenza vaccine].
    Kiseleva IV; Larionova NV; Teley LC; Rudenko LG
    Vopr Virusol; 2011; 56(3):28-32. PubMed ID: 21786624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemagglutinin and neuraminidase genes of influenza B viruses circulating in Riyadh, Saudi Arabia during 2010-2011: evolution and sequence analysis.
    Ali G; Amer HM; Almajhdi FN
    J Med Virol; 2014 Jun; 86(6):1003-16. PubMed ID: 24150926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANTIGENIC AND GENETIC CHARACTERIZATION OF INFLUENZA B VIRUSES IN 2012 FROM SLUMS, DHAKA, BANGLADESH.
    Islam MA; Sultana N; Ahmed F; Rahman MM; Rahman SR
    Southeast Asian J Trop Med Public Health; 2015 Jul; 46(4):611-5. PubMed ID: 26867380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.